Could Contentious IPR Trade Terms Bloat Healthcare Costs, Sink Pharma’s Image?

 
• By Anju Ghangurde
  
Cargo
IPR PROVISIONS IN TRADE DEALS COULD RAISE HEALTHCARE COSTS AND HIT PHARMA'S IMAGE
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Pink Sheet